Skip to main content
. Author manuscript; available in PMC: 2021 Apr 1.
Published in final edited form as: Lancet Digit Health. 2020 Mar 2;2(4):e192–e200. doi: 10.1016/S2589-7500(20)30025-X

Table 1.

Summary Data of CT Biomarkers According to Clinical Outcomes

Summary Data of CT Biomarkers According to Clinical Outcomes
CT Biomarker Total Cohort (n=9223) CV Event Death
Yes (n=1831) No (n=7392) Yes (n=549) No (n=8674)
AoCa (Ag)
Mean 699 1628 469 2471 587
Median 59 449 31 873 48
IQR 0–493 38–1945 0–313 131–3541 0–428
Muscle HU
Mean 28.9 25.4 29.8 20.8 29.4
Median 31 27 31 22 31
IQR 22–38 17–35 23–38 12–31 23–38
V/S Fat Ratio
Mean 0.91 1.13 0.58 1.22 0.89
Median 0.72 0.94 0.68 0.98 0.71
IQR 0.5–1.2 0.6–1.4 0.5–1.1 0.7–1.5 0.5–1.1
Liver HU
Mean 55.4 54.1 55.7 53.6 55.5
Median 58 56 58 56 58
IQR 52–62 50–61 52–62 50–60 52–62
L1 HU
Mean 171.2 159.0 174.2 150.9 172.4
Median 168 156 171 146 169
IQR 142–197 128–186 146–200 113–180 144–198

CV = cardiovascular; AoCa = aortic calcification; Ag = Agatston score; HU = Hounsfield units; V/S = visceral-tosubcutaneous; IQR = interquartile ratio; Subsequent CV events defined as acute MI, CVA, CHF, or death

All comparisons of CT biomarkers with versus without events were statistically significant (p<0.001)